<DOC>
	<DOCNO>NCT00114049</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness GW406381 ( COX-2 inhibitor ) treat sign symptom dental pain follow third molar tooth extraction .</brief_summary>
	<brief_title>Dental Pain ( Following Third Molar Tooth Extraction ) Study</brief_title>
	<detailed_description>A Pivotal Phase III , Single Center , Randomized , Double-Blind , Placebo-Controlled , Parallel Group Dose-Ranging Study Investigate Efficacy Safety Single Oral Doses 10mg , 25mg , 50mg , 70mg GW406381 550mg Naproxen Sodium Subjects With Pain Following Third Molar Tooth Extraction</detailed_description>
	<mesh_term>Toothache</mesh_term>
	<criteria>Inclusion criterion : Scheduled outpatient surgical removal least two third molar teeth . Exclusion criterion : Subjects achieve moderate severe pain . Subjects use acceptable contraception . Additional medical criterion assess investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Dental Pain</keyword>
	<keyword>Dental Surgery</keyword>
	<keyword>Cox-2 inhibitor</keyword>
</DOC>